{"title":"Bedeutung der Palliativmedizin in der Behandlung des Krebskranken","authors":"M. Kloke","doi":"10.1055/S-2000-7504","DOIUrl":"https://doi.org/10.1055/S-2000-7504","url":null,"abstract":"","PeriodicalId":123656,"journal":{"name":"Tumordiagn u Ther","volume":"37 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2000-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133165918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Die multimodale Therapie des Analkarzinoms","authors":"F. Roelofsen","doi":"10.1055/s-2000-8158","DOIUrl":"https://doi.org/10.1055/s-2000-8158","url":null,"abstract":"Mitomycin a significant difference in colostomy free survival for the Mitomycin containing regimen was observed. There was a trend for survival benefit in favour of Mitomycin and less deaths attributed to tumor progression. After a treatment dose of 45 Gy in node negative patients and 50.4 Gy in node positive patients a salvage with additional radiotherapy of 9 Gy with concomitant continuous Fluororuracil and DDP 100 mg/m 2 day 2 was possible in half of the patients. Some of the remaining open questions are adressed in on-going studies.","PeriodicalId":123656,"journal":{"name":"Tumordiagn u Ther","volume":"180 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2000-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122441924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Nachsorge und Rehabilitation noch zeitgemäß?*","authors":"A. Hölscher, T. Bauer","doi":"10.1055/s-2000-8155","DOIUrl":"https://doi.org/10.1055/s-2000-8155","url":null,"abstract":"inquiry of 103 patients with resected solid tumors showed that the tumor aftercare is judged positively by the majority and that the follow-up of these patients should be performed by the institution of primary therapy or in close cooperation with this hospital. From the point of view of surgical oncology, rehabilitation is especially indicated in case of significant underweight, problems of oral food in-take, immobility, necessity of psychologic conduct and lacking of domestic care.","PeriodicalId":123656,"journal":{"name":"Tumordiagn u Ther","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2000-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134231380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Flasshove, J. Leonard, W. Bardenheuer, M. Moore
{"title":"Increased Resistance and Selection in Paclitaxel for Peripheral Blood Progenitor Cells Following Transduction with the MDR1 Gene","authors":"M. Flasshove, J. Leonard, W. Bardenheuer, M. Moore","doi":"10.1055/s-2000-8157","DOIUrl":"https://doi.org/10.1055/s-2000-8157","url":null,"abstract":"Einleitung: Methode: Ergebnisse: in vitro Schlußfolgerung: in vitro Introduction: Methods: Results: in vitro Conclusion: in vitro","PeriodicalId":123656,"journal":{"name":"Tumordiagn u Ther","volume":"130 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2000-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122725823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Der Chirurg als prognostischer Faktor in der onkologischen Chirurgie","authors":"Qualittskontrolle – Qualittssicherung, ·. Karzinom, ·. Chirurgie, –. Morbiditt, –. Mortalitt, ·. Prognose","doi":"10.1055/s-2000-8156","DOIUrl":"https://doi.org/10.1055/s-2000-8156","url":null,"abstract":"The Surgeon(cid:29)s Impact on Outcome in Oncological Surgery. Outcome of cancer patients will be determined by the extend of disease as well as by the quality of treatment. Peri-operative morbidity and mortality usually serve as outcome measures in surgery. In addition, quality of oncological surgery will be indicated by local recurrence and survival rates and an estimation of quality of life as well. Several recent studies have found an inverse relationship between hospital volume and surgeon case load on the one hand and outcome on the other. These findings provide arguments in favor of regionalization of oncological surgery. Another argu-ment for a centralization is the increasing implementation of multimodal treatment protocols in cancer treatment. The present critical review summarizes data on this topic for the most common intestinal cancers.","PeriodicalId":123656,"journal":{"name":"Tumordiagn u Ther","volume":"9 3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2000-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123438001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}